Oppenheimer & Co’s Enlivex Therapeutics ENLV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q3 | – | Sell |
-328
| Closed | -$8K | – | 1318 |
|
|
2017
Q2 | $8K | Sell |
328
-30
| -8% | -$732 | ﹤0.01% | 1294 |
|
|
2017
Q1 | $11K | Sell |
358
-260
| -42% | -$7.99K | ﹤0.01% | 1283 |
|
|
2016
Q4 | $26K | Sell |
618
-450
| -42% | -$18.9K | ﹤0.01% | 1260 |
|
|
2016
Q3 | $73K | Sell |
1,068
-222
| -17% | -$15.2K | ﹤0.01% | 1229 |
|
|
2016
Q2 | $82K | Sell |
1,290
-272
| -17% | -$17.3K | ﹤0.01% | 1174 |
|
|
2016
Q1 | $155K | Sell |
1,562
-410
| -21% | -$40.7K | ﹤0.01% | 1145 |
|
|
2015
Q4 | $305K | Buy |
1,972
+87
| +5% | +$13.5K | 0.01% | 951 |
|
|
2015
Q3 | $384K | Buy |
1,885
+106
| +6% | +$21.6K | 0.01% | 905 |
|
|
2015
Q2 | $490K | Buy |
1,779
+525
| +42% | +$145K | 0.01% | 885 |
|
|
2015
Q1 | $301K | Buy |
1,254
+847
| +208% | +$203K | 0.01% | 1106 |
|
|
2014
Q4 | $104K | Buy |
+407
| New | +$104K | ﹤0.01% | 1323 |
|